151. Nationwide survey of patients with primary immunodeficiency diseases in Japan.
- Author
-
Ishimura M, Takada H, Doi T, Imai K, Sasahara Y, Kanegane H, Nishikomori R, Morio T, Heike T, Kobayashi M, Ariga T, Tsuchiya S, Nonoyama S, Miyawaki T, and Hara T
- Subjects
- Adolescent, Agammaglobulinaemia Tyrosine Kinase, Antibodies genetics, Antibodies immunology, Autoimmunity genetics, Child, Female, Health Surveys, Humans, Immunoglobulin A genetics, Immunologic Deficiency Syndromes genetics, Immunologic Deficiency Syndromes immunology, Japan epidemiology, Male, Phagocytes immunology, Phagocytes pathology, Prevalence, Protein-Tyrosine Kinases genetics, Surveys and Questionnaires, Antibodies metabolism, Immunologic Deficiency Syndromes epidemiology, Immunologic Deficiency Syndromes physiopathology, Phagocytes metabolism
- Abstract
To determine the prevalence and clinical characteristics of patients with in Japan, we conducted a nationwide survey of primary immunodeficiency disease (PID) patients for the first time in 30 years. Questionnaires were sent to 1,224 pediatric departments and 1,670 internal medicine departments of Japanese hospitals. A total of 1,240 patients were registered. The estimated number of patients with PID was 2,900 with a prevalence of 2.3 per 100,000 people and homogenous regional distribution in Japan. The male-to-female ratio was 2.3:1 with a median age of 12.8 years. Adolescents or adults constituted 42.8% of the patients. A number of 25 (2.7%) and 78 (8.5%) patients developed malignant disorders and immune-related diseases, respectively, as complications of primary immunodeficiency disease. Close monitoring and appropriate management for these complications in addition to prevention of infectious diseases is important for improving the quality of life of PID patients.
- Published
- 2011
- Full Text
- View/download PDF